JOINN Releases 2025 AGM Circular: Profit Distribution Plan, Articles Amendments and 2026 Restricted A-Share Incentive Scheme Highlight Agenda

Bulletin Express
05/12

JOINN Laboratories (China) Co., Ltd. published a comprehensive circular on 13 May 2026 detailing matters to be tabled at its 2025 annual general meeting and the first H-share class meeting of 2026.

Key items in the circular:

1. 2025 Operating Documents • Release of the 2025 annual report and summary. • Review of the Board of Directors’ 2025 work report.

2. Capital Allocation • Proposal of the 2025 profit distribution plan; specific payout figures were not disclosed in the notice.

3. Governance Framework • Proposed amendments to the Articles of Association and to the Rules of Procedures of the General Meeting of Shareholders. • Proposed formulation of the Management Rules on Remuneration for Directors and Senior Management. • Proposal on overall director remuneration for the year.

4. Board Composition and Audit Oversight • Proposed appointment of a non-executive director. • Proposed re-appointment of the external auditors for 2026.

5. Equity Incentive Arrangements • Proposed adoption of the 2026 Restricted A-Share Incentive Scheme. • Proposed adoption of the associated Assessment Administrative Measures. • Proposed authorization for the Board to handle all matters related to the incentive plan.

6. Shareholder Meetings • Notice of the 2025 annual general meeting. • Notice of the first H-share class meeting of 2026. • Distribution of proxy forms for both meetings.

The full English and Chinese versions of the circular and related documents are now available on JOINN’s corporate website and on the Hong Kong Stock Exchange’s disclosure platform. Printed copies can be requested through Tricor Investor Services Limited, the company’s H-share registrar in Hong Kong, at no cost to shareholders who prefer hard copies.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10